THE Miton Arcturus Cautious Absolute Return fund has acquired two new funds in the commodities and specialist sectors.
The Axa Framlington Biotech fund was acquired on 16 July and represents Miton’s first foray back into the biotech sector for some years. The second half of the year generally sees more activity in the biotech sector driven by inflows of clinical news data, and according to fund manager Tom McGrath: “After years of underperformance there could be plenty of M&A activity and the sector could move.” The commodity growth story influenced McGrath’s purchase of the Schroder Agricultural fund on July 4. “The growth in population and farmers’ predilection to plant for biofuel rather than ru...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes